Skip to main content
. 2014 Apr 1;124(4):1430–1438. doi: 10.1172/JCI71029

Figure 2. Schematic of various suitable routes of drug delivery for treatment of AMD.

Figure 2

Drugs to be delivered to the target area (macula with foveola) can be administered topically to the surface of the eye (eye drops), underneath the conjunctiva for transscleral delivery (subconjunctival injection/implant, parabulbar injection), directly into the vitreous (intravitreal injection/implant), or systemically (oral, intravenous infusion).